HomeOpen Access NewsDrug Development

Drug Development

Subscribe to Updates

iDOMO: New AI tool predicts synergistic drug combinations

Pharma
Researchers at Mount Sinai have developed iDOMO, a powerful AI tool that predicts synergistic drug combinations for complex diseases like cancer.

Getting personal in brain tumour therapy: Matching therapies to patients

Health & Social Care
Sean E. Lawler PhD from Brown University Cancer Center, an experienced scientist in the brain tumour field

Metformin: A possible new treatment for endometriosis

Health & Social Care
Dr Deborah Lee, Dr Fox Online Pharmacy, discusses a possible new treatment for endometriosis - the condition that impacts atleast 1.5 million women in the UK.

New Pfizer Covid-19 pill seeking emergency use authorization from FDA

Pharma
Pfizer have announced that it is seeking emergency use authorization for its new Covid-19 oral antiviral candidate PAXLOVID™

How to compete with COVID-19 with a computer?

Research & Innovation
Y-h. Taguchi, Professor at Chuo University in Japan, reveals how to compete with COVID-19 by using a computer.

Pfizer COVID-19 pill 89% effective against death

Research & Innovation
Pfizer has announced that its antiviral pill, PAXLOVID, is 89% effective in reducing COVID-19 hospitalisation and death.

New “clickable” COVID vaccine patch in early stages of testing

Research & Innovation
The University of Texas is creating a COVID vaccine patch, which can protect against the virus - without the use of a needle.

UK creates deal for 480,000 doses of Merck COVID pill

Health & Social Care
The Merck COVID pill, molnupiravir, cuts risk of death by 50% - now, the UK have secured 480,000 doses for late 2021.

New cancer treatment creates best “overall survival ever”

Cancer Research
A new cancer treatment, an immunotherapy combination as opposed to gruelling chemotherapy, is saving the lives of head and neck cancer patients.

Neuromodulation clears symptoms of severe, untreatable depression

Mental Health
Targeted neuromodulation may be a future method to help those with severe, untreatable depression - traditionally, this is used to correct misfiring brain circuits in people with epilepsy or Parkinson's.

Changing the treatment paradigm in Inflammatory Bowel Diseases

Diseases & Conditions
Prof. Hartmut J. Ehrlich, M.D., CEO of Abivax, explains why drug-candidate ABX464 has the potential to address the urgent need for new, safe short- and long-term effective drugs to treat Inflammatory Bowel Diseases.

Glycoscience offers opportunities galore in healthcare

Health & Social Care
Aarthi JanakiRaman, Research Director, Chemicals and Advanced Materials at TechVision, Frost & Sullivan, explains how glycoscience offers opportunities galore in healthcare.

NICE recommends use of cholesterol-lowering drug

Health & Social Care
The National Institute for Health and Care Excellence (NICE) believes that Inclisiran, a cholesterol-lowering drug, should be available on the NHS.

Malaria deaths reduced by 70% with vaccine and drug combination

Diseases & Conditions
A combination of the world’s first malaria vaccine RTS,S/AS01E and antimalarial drugs reduce child hospitalisations and death by 70%.

Study with one million vaccinated people finds AstraZeneca is safe

Research & Innovation
The study, pre-printed in The Lancet, found that blood clots were far more common in people with COVID-19 than people vaccinated with AstraZeneca.

Blood clotting from severe COVID-19 caused by abnormal antibodies

Health & Social Care
Blood clotting and inflammation seen in very severe COVID-19 cases may be caused by abnormal antibodies, according to a new study.

Immunologists push for more intranasal COVID vaccines

Health & Social Care
While intramuscular vaccines are the norm right now, immunologists propose that intranasal COVID vaccines would be great for booster shots.
1...78910Page 8 of 10

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders

Visit Article Archive
Open Access Government

Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.

Follow Us

Resources

Quick Links

Legal & Marketing

As a Crossref Sponsored Member we are able to connect your content with a global network of online scholarly research, currently over 20,000 other organizational members from 160 countries. Crossref drive metadata exchange and support nearly 2 billion monthly API queries, facilitating global research communication.

© Adjacent Digital Politics Ltd